drugset / Trial / NCT06426537
Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches
RandomizedParallel-groupSingle-blindSupportive care
Summary
This study investigates the effect of Colchicine in preventing heart structure changes following ST-segment elevation myocardial infarction. Through a clinical trial involving patients requiring coronary intervention, we explore how Colchicine can reduce inflammation and fibrosis, two crucial factors influencing heart failure post-heart attack. The outcomes are expected to offer new insights into post-heart attack treatments to prevent heart failure.
Timeline
- Start
- 2022-10-20
- Primary completion
- 2023-03-25
- Completion
- 2023-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Colchicine | Small molecule | 0.5 mg | Oral |